<DOC>
	<DOCNO>NCT02331472</DOCNO>
	<brief_summary>This study evaluate efficacy urine biomarker patient interstitial cystitis/painful bladder syndrome</brief_summary>
	<brief_title>The Efficacy Urine Biomarker Patient With Interstitial Cystitis/Painful Bladder Syndrome ( Pilot Study )</brief_title>
	<detailed_description />
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<criteria>1. must experience bladder pain , urinary urgency frequency least 6 month prior entry study 2 . Pain VAS &gt; 4 3 . PUF score &gt; 13 4 . ICQ score &gt; 12 4 ) cystoscopic record within 2years 1 . Patients pregnancy , childbearing age without contraception 2 . Patient microscopic hematuria , exclude evidence neoplastic tumor examination 3. patient urine culture show evidence urinary tract infection 1month prior study 4 . Accompanied medical problem Tuberculosis urinary system Bladder cancer , urethral cancer , Prostate cancer Recurrent cystitis Anatomical disorder 5 . Patients prior surgery ( bladder augmentation , cystectomy ) 6 . Patients neurologic disorder 7 . Patients indwell catheter intermittent selfcatheterization 8 . Patients psychological problem</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>interstitial cystitis</keyword>
	<keyword>biomarker</keyword>
</DOC>